Eppdata is uniquely positioned to support the lifecycle of clinical studies with information technology development and domain specific medical expertise.

Joined January 2025
4 Photos and videos
24 Jul 2025
Congratulations! We keep up with the ratings. Promised. @CheesemakerMD @FishingNeurons @StrokeEso79453
23 Jul 2025
We’ve just enrolled the 100th patient in the #TECNO trial πŸ’ΏπŸŽ‰ A huge thank you to all sites, teams, and patients for making this progress possible πŸ™
2
43
24 Jul 2025
Congratulations: Great engineering and impressive results. TICI double read with full end-to-end traceability. Proud to be part of your journey! @Fie0815 @RaulNogueiraMD
16 Jul 2025
Preliminary results from the MARRS pivotal IDE trial were presented at @SNISinfo, highlighting Millipede88 performance in acute ischemic stroke: πŸ”Ή 77% First Pass Effect for M1 occlusions πŸ”Ή 99% Delivery success πŸ”Ή Promising safety profile bit.ly/3Gu2mFT @Wayne_Perfuze
1
29
18 Mar 2025
ERASER is the first mechanical thrombectomy study with a primary endpoint based on predictive analytics enabling intraindividual virtual comparisons. This innovative study design paves the way for faster, more reliable evaluations in clinical trials. #Stroke #NeuroIntervention
1
998
11 Mar 2025
MMA embolization reduces treatment failures in chronic subdural hematoma by over 50%. Eppdata provided core lab services for the STEM trial. Read more at the NEJM: bit.ly/3DH8Ak0 Interested in advancing your research? πŸ“© Contact us today! #MedicalResearch
3
4
398
4 Mar 2025
Trustworthy data is the cornerstone of any successful clinical trial. At Eppdata we're committed to : Secure Data Handling Standardized Imaging Protocols Unbiased Analysis Ready to elevate your research? πŸ“© Contact us today! #dataIntegrity #corelab #MedicalResearch
2
81
27 Feb 2025
Eppdata provided core lab services for the TENSION trial, proving that patients with large infarcts benefit from endovascular thrombectomy. Check out recent The Lancet publication: lnkd.in/gj4SZKYQ πŸ“© Contact us to collaborate on your next neurovascular trial! #corelab
1
2
875